New aspects of an old drug: Diclofenac targets MYC and glucose metabolism in tumor cells

URN to cite this document:: urn:nbn:de:bvb:355-epub-295458
DOI to cite this document:: 10.5283/epub.29545

Kreutz, Marina ; Gottfried, Eva ; Lang, Sven A. ; Renner, Kathrin ; Bosserhoff, Anja-Katrin ; Gronwald, Wolfram ; Rehli, Michael ; Einhell, Sabine ; Gedig, Isabel ; Singer, Katrin ; Seilbeck, Anton ; Mackensen, Andreas ; Grauer, Oliver ; Hau, Peter ; Dettmer, Katja ; Andreesen, Reinhard ; Oefner, Peter

Preview

License: Creative Commons: Attribution 3.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 12 Feb 2014 13:05

Alternative links to fulltext:DOI

Details

Preview

Export bibliographical data

Abstract

Non-steroidal anti-inflammatory drugs such as diclofenac exhibit potent anticancer effects. Up to now these effects were mainly attributed to its classical role as COX-inhibitor. Here we show novel COX-independent effects of diclofenac. Diclofenac significantly diminished MYC expression and modulated glucose metabolism resulting in impaired melanoma, leukemia, and carcinoma cell line ...